McNeill Consumer & Specialty Pharmaceuticals

McNeil Consumer & Specialty Pharmaceuticals was a major division of Johnson & Johnson, primarily responsible for some of the world's most recognized over-the-counter (OTC) healthcare brands. The company's portfolio included market leaders such as Tylenol (acetaminophen), Motrin (ibuprofen), and Zyrtec (cetirizine). It played a critical role in the Rx-to-OTC switch process, bringing formerly prescription-only medications directly to consumers. In 2023, as part of Johnson & Johnson's strategic separation of its consumer health business, McNeil's brands and operations became part of the newly independent company, Kenvue. The company is also historically noted for its industry-leading response to the 1982 Tylenol crisis, which revolutionized product safety packaging.